CAMLPR Specimen Collection Competency Practice Test

Why is it important to document medications and supplements that may affect test results before collection?

Substances can interfere with assays; documenting allows correct interpretation and appropriate retesting if needed.

Substances taken before a test can interact with lab assays and change the result you’ll see on the report. Medications and supplements may alter the analyte being measured, interfere with the assay’s chemistry, or affect specimen quality. When you document everything the patient is taking, the lab and clinician can interpret results accurately, recognize potential interference, and decide whether retesting or using an alternative method is needed. This helps prevent misinterpretation that could lead to incorrect treatment, and it guides decisions about whether a repeat collection is necessary.

Examples show why this matters: high-dose biotin can skew many immunoassays; certain anticoagulants change clotting tests; some vitamins and herbal supplements can affect chemistry panels. Without documenting these substances, results might be mistaken, and efforts to verify or treat based on those results could be misguided.

The other ideas aren’t correct because substances can and do impact results, documentation isn’t only for billing, and lists aren’t optional or rarely reviewed in practice.

They have no impact on test results.

Documentation is only for billing purposes.

Medication lists are optional and rarely reviewed.